Donna Cummings signed Relmada Therapeutics Inc.'s 2025 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Relmada Therapeutics Inc.'s EIN is 20-8506626.
Download the official 2025 Form 5500 (PDF) for Relmada Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.
Download the official 2025 Form 5500 (PDF)Relmada Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).